Study Stopped
Funding unavailable
Intervention for Caregivers of Patients Who Have Recently Undergone HSCT
A Pilot Study to Evaluate the Feasibility of an Intervention for Caregivers of Patients Who Have Recently Undergone HSCT
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The purpose of this study is to find out if providing support to caregivers of patients who have recently had a HSCT is possible and helpful.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2020
CompletedFirst Posted
Study publicly available on registry
November 20, 2020
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedMay 25, 2021
May 1, 2021
5 months
November 19, 2020
May 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Acceptability Scale scores
Caregiver Acceptability as measured by Acceptability Scale scores. Overall score ranging from 6-30. According to prior research, a score of 80% of higher (total score of 24 or higher) is considered acceptable for use.
At 2 months
System Usability Scale scores
Caregiver Usability as measured by the System Usability Scale. This is a 10 item scale scored on a 5 point Likert scale with total summed scores ranging from 0-50. Total scores are multiplied by 2 to produce an overall score ranging from 0-100 with scores \> 68 considered to be above average usability
At 2 months
Mean caregiver satisfaction scores
Caregiver Satisfaction scores as measured by Likert Scale. After completing each module, they will be sent via REDCap a single item evaluation scale (0 -10; 0=Not at all satisfied; 10=Highly satisfied). Scores \>7 will be considered acceptable. Mean and standard deviation will be reported.
At the end of each intervention session and end of study evaluation, up to 2 months
Percent of enrollment of eligible participants
Feasibility as measured by percent of enrollment of eligible participants
At 2 months
Percent of participants completing intervention
Feasibility as measured by intervention completion
At 2 months
Retention rate
Feasibility as measured by percent of participants retained in full study (aim: 90% retention at the end of the 2-month intervention)
At 2 months
Average time to recruit dyads in months
Feasibility as measured by time to identify and recruit dyads in months (benchmark 3 months)
At 2 months
Data collection completion rate
Feasibility as measured by completion of data collection across study timepoints
At 2 months
Secondary Outcomes (3)
NCCN Distress Thermometer scores
At baseline and at 2 months
PROMISR Short Form v1.0 - Anxiety
At baseline and at 2 months
PROMISRv.1.2 - GlobalHealth scores
At baseline and at 2 months
Study Arms (1)
Psycho-educational intervention
EXPERIMENTALAll participants will receive receive 4 individual sessions with an interventionist in addition to the standard post-hospital HSCT information for patient follow-up care as provided by the patient's oncologist
Interventions
Participant will be sent a baseline survey, and will then be contacted by the interventionist to complete 4 sessions, which feature the following areas: Session 1: Identifying CG Needs for Information \& Support, Communication with Healthcare Team Session 2: Communication with Patient and Family Session 3: Self-care: Emotional \& Spiritual Needs, Self-care: Physical Needs Session 4: Re-Assessing Needs, Planning for the future
Eligibility Criteria
You may qualify if:
- An adult family or friend of a patient who has been discharged from the hospital in the past 1-2 weeks after receiving HSCT
- Identifies himself/herself as the caregiver who will be responsible for the patient's care post-HSCT
- Has English as their primary language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Douglas, PhD, RN
Case Western Reserve University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2020
First Posted
November 20, 2020
Study Start
June 1, 2021
Primary Completion
November 1, 2021
Study Completion
November 1, 2021
Last Updated
May 25, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share
This is a pilot study to only test the intervention so the data would not be useful to participants until a larger study (with control and intervention groups) is completed in the future